237 Users Online
Intracranial Therapeutic Delivery Market Segmented By Cell-based Therapy, Gene Therapy, Enzyme Replacement Therapy with Spinal Muscular Atrophy, Multiple Sclerosis, Batten Disease, Amyotrophic Lateral Sclerosis Indication
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions / Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Key Promotional Strategies, By Manufacturers
4.3. Porter’s Analysis
4.4. PESTLE Analysis
4.5. Value Chain
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. GDP Growth forecast
5.2.3. Strategic Collaborations among Players
5.2.4. Rising Number of Pipeline Products for Gene-Based Therapies
5.2.5. Growing prevalence of Neurologic Diseases
5.2.6. Entries of new start-up companies in the market
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. 2021 Market Scenario
6.2. COVID-19 and Impact Analysis
6.2.1. Revenue by Therapy
6.2.2. Revenue by Indication
6.2.3. Revenue by Country
7. Global Intracranial Therapeutic Delivery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, By Therapy
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Trend Analysis By Therapy, 2017–2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy, 2022–2032
8.3.1. Cell-Based Therapy
8.3.2. Gene Therapy
8.3.3. Enzyme Replacement Therapy
8.4. Market Attractiveness Analysis By Therapy
9. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, by Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2017–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032
9.3.1. Spinal Muscular Atrophy (SMA)
9.3.2. Multiple Sclerosis
9.3.3. Batten Disease
9.3.4. Amyotrophic lateral sclerosis
9.4. Market Attractiveness Analysis By Indication
10. Global Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis, By Region, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
10.3.1. U.S.
10.3.2. Europe
10.3.3. Rest of the World (ROW)
10.4. Market Attractiveness Analysis By Region
11. U.S Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
11.3.1. By Therapy
11.3.2. By Indication
11.4. Market Attractiveness Analysis
11.4.1. By Therapy
11.4.2. By Indication
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis
12. Europe Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Nordic Countries
12.3.1.8. Russia
12.3.1.9. Rest of Europe
12.3.2. By Therapy
12.3.3. By Indication
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Therapy
12.4.3. By Indication
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. Germany Intracranial Therapeutic Delivery Market
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast by Market Taxonomy
12.7.1.2.1. By Therapy
12.7.1.2.2. By Indication
12.7.2. France Intracranial Therapeutic Delivery Market
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast by Market Taxonomy
12.7.2.2.1. By Therapy
12.7.2.2.2. By Indication
12.7.3. Italy Intracranial Therapeutic Delivery Market
12.7.3.1. Introduction
12.7.3.2. Market Analysis and Forecast by Market Taxonomy
12.7.3.2.1. By Therapy
12.7.3.2.2. By Indication
12.7.4. Spain Intracranial Therapeutic Delivery Market
12.7.4.1. Introduction
12.7.4.2. Market Analysis and Forecast by Market Taxonomy
12.7.4.2.1. By Therapy
12.7.4.2.2. By Indication
12.7.5. U.K. Intracranial Therapeutic Delivery Market
12.7.5.1. Introduction
12.7.5.2. Market Analysis and Forecast by Market Taxonomy
12.7.5.2.1. By Therapy
12.7.5.2.2. By Indication
12.7.6. Benelux Union Intracranial Therapeutic Delivery Market
12.7.6.1. Introduction
12.7.6.2. Market Analysis and Forecast by Market Taxonomy
12.7.6.2.1. By Therapy
12.7.6.2.2. By Indication
12.7.7. Nordic Countries Intracranial Therapeutic Delivery Market
12.7.7.1. Introduction
12.7.7.2. Market Analysis and Forecast by Market Taxonomy
12.7.7.2.1. By Therapy
12.7.7.2.2. By Indication
12.7.8. Russia Intracranial Therapeutic Delivery Market
12.7.8.1. Introduction
12.7.8.2. Market Analysis and Forecast by Market Taxonomy
12.7.8.2.1. By Therapy
12.7.8.2.2. By Indication
13. Rest of the World (ROW) Intracranial Therapeutic Delivery Market Analysis 2017-2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
13.3.1. By Therapy
13.3.2. By Indication
13.4. Market Attractiveness Analysis
13.4.1. By Therapy
13.4.2. By Indication
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Market Structure Analysis
14.1. Market Analysis by Tier of Companies
14.2. Market Share Analysis of Top Players
14.3. Market Presence Analysis
14.3.1. By Regional footprint of Players
14.3.2. Product footprint by Players
14.3.3. Channel Foot Print by Players
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Competition Deep Dive [Tentative list]
15.3.1. Novartis AG
15.3.1.1. Overview
15.3.1.2. Product Portfolio
15.3.1.3. Key Financials
15.3.1.4. SWOT Analysis
15.3.1.5. Sales Footprint
15.3.1.6. Strategy Overview
15.3.1.7. Key Developments
15.3.2. BioMarin
15.3.2.1. Overview
15.3.2.2. Product Portfolio
15.3.2.3. Key Financials
15.3.2.4. SWOT Analysis
15.3.2.5. Sales Footprint
15.3.2.6. Strategy Overview
15.3.2.7. Key Developments
15.3.3. CORESTEM Inc.
15.3.3.1. Overview
15.3.3.2. Product Portfolio
15.3.3.3. Key Financials
15.3.3.4. SWOT Analysis
15.3.3.5. Sales Footprint
15.3.3.6. Strategy Overview
15.3.3.7. Key Developments
15.3.4. Alaunos Therapeutics, Inc.
15.3.4.1. Overview
15.3.4.2. Product Portfolio
15.3.4.3. Key Financials
15.3.4.4. SWOT Analysis
15.3.4.5. Sales Footprint
15.3.4.6. Strategy Overview
15.3.4.7. Key Developments
15.3.5. Apic Bio
15.3.5.1. Overview
15.3.5.2. Product Portfolio
15.3.5.3. Key Financials
15.3.5.4. SWOT Analysis
15.3.5.5. Sales Footprint
15.3.5.6. Strategy Overview
15.3.5.7. Key Developments
15.3.6. Stemedica Cell Technologies, Inc.
15.3.6.1. Overview
15.3.6.2. Product Portfolio
15.3.6.3. Key Financials
15.3.6.4. SWOT Analysis
15.3.6.5. Sales Footprint
15.3.6.6. Strategy Overview
15.3.6.7. Key Developments
15.3.7. Voyager Therapeutics
15.3.7.1. Overview
15.3.7.2. Product Portfolio
15.3.7.3. Key Financials
15.3.7.4. SWOT Analysis
15.3.7.5. Sales Footprint
15.3.7.6. Strategy Overview
15.3.7.7. Key Developments
15.3.8. Bayer AG
15.3.8.1. Overview
15.3.8.2. Product Portfolio
15.3.8.3. Key Financials
15.3.8.4. SWOT Analysis
15.3.8.5. Sales Footprint
15.3.8.6. Strategy Overview
15.3.8.7. Key Developments
15.3.9. Abeona Therapeutics
15.3.9.1. Overview
15.3.9.2. Product Portfolio
15.3.9.3. Key Financials
15.3.9.4. SWOT Analysis
15.3.9.5. Sales Footprint
15.3.9.6. Strategy Overview
15.3.9.7. Key Developments
15.3.10. Spark Therapeutics
15.3.10.1. Overview
15.3.10.2. Product Portfolio
15.3.10.3. Key Financials
15.3.10.4. SWOT Analysis
15.3.10.5. Sales Footprint
15.3.10.6. Strategy Overview
15.3.10.7. Key Developments
16. Assumptions and Acronyms Used
17. Research Methodology
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy
Table 02: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication
Table 03: U.S. & Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Region
Table 04: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy
Table 05: U.S. Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication
Table 06: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy
Table 07: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication
Table 08: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Country
Table 09: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Therapy
Table 10: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, By Indication
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021
Figure 02: Global Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032
Figure 03: Global Intracranial Therapeutic Delivery Market Absolute $ Opportunity, 2022–2032
Figure 04: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Therapy, 2022 & 2032
Figure 05: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032
Figure 06: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Indication, 2022 & 2032
Figure 07: Global Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032
Figure 08: Global Intracranial Therapeutic Delivery Market Share Analysis (%), By Region, 2022 & 2032
Figure 09: U.S. Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
Figure 10: U.S. Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
Figure 11: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 12: U.S Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 13: U.S. Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021
Figure 14: U.S. Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032
Figure 15: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032
Figure 16: U.S. Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032
Figure 17: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 18: Europe Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 19: Europe Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
Figure 20: Europe Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
Figure 21: Europe Intracranial Therapeutic Delivery Market Share By Country 2022 (E)
Figure 22: Europe Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021
Figure 23: Europe Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032
Figure 24: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032
Figure 25: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032
Figure 26: Europe Intracranial Therapeutic Delivery Market Attractiveness Analysis By Country, 2022–2032
Figure 27: Germany Market Value Proportion Analysis, 2021
Figure 28: Germany Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 29: Germany Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 30: Italy Market Value Proportion Analysis, 2021
Figure 31: Italy Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 32: Italy Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 33: Spain Market Value Proportion Analysis, 2021
Figure 34: Spain Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 35: Spain Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 36: France Market Value Proportion Analysis, 2021
Figure 37: France Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 38: France Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 39: U.K. Market Value Proportion Analysis, 2021
Figure 40: U.K. Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 41: U.K. Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 42: BENELUX Market Value Proportion Analysis, 2021
Figure 43: BENELUX Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 44: BENELUX Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 45: Nordic Countries Market Value Proportion Analysis, 2021
Figure 46: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 47: Nordic Countries Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 48: Russia Market Value Proportion Analysis, 2021
Figure 49: Russia Intracranial Therapeutic Delivery Market Share Analysis(%) By Therapy, 2021 & 2032
Figure 50: Russia Intracranial Therapeutic Delivery Market Share Analysis (%) By Indication, 2021 & 2032
Figure 51: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 52: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Size (US$ Mn) Analysis, 2022E & 2032F
Figure 53: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Therapy 2022 (E)
Figure 54: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Share By Indication 2022 (E)
Figure 55: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Analysis (US$ Mn), 2017–2021
Figure 56: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Value Forecast (US$ Mn), 2022–2032
Figure 57: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Therapy, 2022–2032
Figure 58: Rest of the world (ROW) Intracranial Therapeutic Delivery Market Attractiveness Analysis By Indication, 2022–2032
